ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in biomarker imaging technologies for the early ...

Magnetic resonance elastography (MRE) is a new, noninvasive imaging test that accurately detects fibrosis in children, including those who are severely obese, with nonalcoholic fatty liver disease ...

This multi-target blood test "offers the potential for improved patient outcomes through earlier HCC detection," John said ...

Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent chronic liver disorders worldwide and can sometimes lead to severe conditions like cirrhosis and hepatocellular carcinoma. As such ...

Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.

According to the Centers for Disease Control and Prevention (CDC), approximately 25,000 men and 11,000 women are diagnosed with liver cancer each year. Early detection and treatment are key to ...

The retrospective phase 2b study, which explored the use of various non-invasive tests (NITs) to assess response to semaglutide, adds to growing evidence that the drug not only improves metabolic ...

IRVINE & TEMPLE CITY, Calif.--(BUSINESS WIRE)--Helio Health (“Helio”) and its commercial partner, Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), today announced the commercial launch of ...

Yes, it is possible for a person with cirrhosis to receive typical liver function test results, although this is rare. The United Kingdom’s National Health Service (NHS) notes that liver function ...

Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.